BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 43
- Registration Number
- NCT02933450
- Locations
- 🇺🇸
Ben Taub Hospital, Houston, Texas, United States
Low VW Activity in Adolescent HMB
Active, not recruiting
- Conditions
- Von Willebrand Factor Deficiency
- Interventions
- Other: Genetic AnalysisOther: Medical Record Data AbstractionOther: Pictorial Blood Assessment Chart (PBAC) scoreOther: Complete Bleeding Symptom ISTH Bleeding Assessment Tool
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 120
- Registration Number
- NCT02933411
- Locations
- 🇺🇸
Children's Hospital of Atlanta, Atlanta, Georgia, United States
🇺🇸Joseph M Sanzari Children's Hospital, Hackensack, New Jersey, United States
🇺🇸Michigan State University, East Lansing, Michigan, United States
Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
Phase 1
Active, not recruiting
- Conditions
- Liver Cancer
- Interventions
- First Posted Date
- 2016-10-13
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT02932956
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Cognition in Motion
Not Applicable
Completed
- Conditions
- Cognitive Performance During Physical Activity
- First Posted Date
- 2016-10-07
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 88
- Registration Number
- NCT02927275
- Locations
- 🇺🇸
Baylor College of Medicine-Department of Obstetrics & Gynecology, Houston, Texas, United States
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Phase 1
Recruiting
- Conditions
- Non-Hodgkin LymphomaHodgkin's Lymphoma
- Interventions
- Genetic: CAR T Cells
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT02917083
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
Dexmedetomidine vs Placebo for Pediatric Cleft Palate Repair
- First Posted Date
- 2016-09-26
- Last Posted Date
- 2019-02-05
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT02915042
Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
Phase 1
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 9
- Registration Number
- NCT02905188
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Throat and Other HPV-Related Cancers in Men: Identifying Them Early
Active, not recruiting
- Conditions
- Human Papillomavirus Infection
- Interventions
- Other: Biomarker AnalysisProcedure: Biospecimen CollectionProcedure: Ultrasonography
- First Posted Date
- 2016-09-13
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 1500
- Registration Number
- NCT02897427
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Phase 1
Active, not recruiting
- Conditions
- Bladder Cancer
- Interventions
- First Posted Date
- 2016-09-01
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT02885974
- Locations
- 🇺🇸
Baylor Clinic, Houston, Texas, United States
🇺🇸Harris Health System - Smith Clinic, Houston, Texas, United States
Strengths-Based Behavioral mHealth App for Parents of Adolescents With Type 1 Diabetes-Pilot Study
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Behavioral: T1Doing Well
- First Posted Date
- 2016-08-24
- Last Posted Date
- 2020-09-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 82
- Registration Number
- NCT02877680
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath